Type 1 Diabetes, Cardiovascular Complications and Sesame (芝麻 Zhī Má)

10.4103/2225-4110.124817

Yen-Chang Lin；Trần Dương Thùy；Shu-Yin Wang；Pung-Ling Huang

Cardiovascular diseases ； Chinese herbal medicines ； Type 1 diabetes

Journal of Traditional and Complementary Medicine

4卷1期（2014 / 01 / 01）

36 - 41

英文

Diabetes is a major concern among medical practitioners, with the annual mortality rate increasing up to 26.9% in a person aged 65 years or older and 11.3% in the adult. There are many serious complications associated with diabetes, particularly cardiovascular complications due to microvascular diseases. A prerequisite to reduce the risk of microvascular and neurologic complications of type 1 diabetes is normoglycemia. Insulin therapy is the most common treatment used nowadays in type 1 diabetes. However, this method still has many disadvantages such as increased episode of severe hypoglycemia, hypoglycemia unawareness, increased weight gain, transient exacerbation of pre-existing retinopathy, etc. Using insulin pump (the insulin pump is a medical device used for continuous subcutaneous insulin infusion to manage the insulin level in the treatment of diabetes mellitus), is associated with known disadvantages including increased ketoacidosis, infection at the infusion site, and the treatment being less suitable in young children (less than 7 years of age). Therefore, alternative treatment for diabetes is still in great demand. We took the approach of traditional Chinese medicine to discuss this matter. Sesame (芝麻 Zhī Má), a herb, has been used medicinally for thousands of years in almost all the countries in the world. The beneficial effects of sesame in remediating diabetes, such as hypoglycemic effects, antioxidant, anti-inflammatory, and hypolipidemic effects, improving fat metabolism, and reducing cholesterol, have been demonstrated in many studies,. However, reports on the effects of sesame in remediating cardiovascular complications in diabetic patients are limited, which necessitates further studies on the effects of sesame on cardiovascular complications.

1. Akhani, SP,Vishwakarma, SL,Goyal, RK(2004).Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats.J Pharm Pharmacol,56,101-105.
2. Alwan, A,MacLean, DR,Riley, LM,d’Espaignet, ET,Mathers, CD,Stevens, GA(2010).Chronic diseases: Chronic diseases and development. Monitoring and surveillance of chronic non-communicable diseases: Progress and capacity in high-burden countries.Lancet,376,1861-1868.
3. American Diabetes Association. Data from the 2011 national diabetes fact sheet. Diabetes Stat 1-4, 2011.
4. American Diabetes Association(2012).Standards of medical care in diabetes.Diabetes Care,35(Suppl 1),S11-S63.
5. Ashraff, S,Siddiqui, MA,Carline, TE(2013).The psychosocial impact of diabetes in adolescents: A review.Oman Med J,28,159-162.
6. Boucek, P(2013).Diabetic nephropathy/diabetic kidney disease.Vnitr Lek,59,201-203.
7. Ceylan-Isik, AF,Fliethman, RM,Wold, LE,Ren, J(2008).Herbal and traditional Chinese medicine for the treatment of cardiovascular complications in diabetes mellitus.Curr Diabetes Rev,4,320-328.
8. Chandrasekaran, VR,Hsu, DZ,Liu, MY(2013).Beneficial effect of sesame oil on heavy metal toxicity.JPEN J Parenter Enteral Nutr
9. Cheung, N,Wang, JJ,Rogers, SL,Brancati, F,Klein, R,Sharrett, AR(2008).Diabetic retinopathy and risk of heart failure.J Am Coll Cardiol,51,1573-1578.
10. Cui, TH,Li, YY(2012).Treatment of type 2 diabetes mellitus oral Chinese patent medicine literature metrology analysis.Zhongguo Zhong Yao Za Zhi,37,2649-2652.
11. Dahl-Jørgensen, K,Larsen, JR,Hanssen, KF(2005).Atherosclerosis in childhood and adolescent type 1 diabetes: Early disease, early treatment?.Diabetologia,48,1445-1453.
12. Delmonte, V,Peixoto, EM,Poggioli, R,Enfield, G,Luzi, L,Ricordi, C(2013).Ten years’ evaluation of diet, anthropometry, and physical exercise adherence after islet allotransplantation.Transplant Proc,45,2025-2028.
13. Diabetes Control and Complications Trial Research Group(1994).Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial Research Group.J Pediatr,125,177-188.
14. Donaghue, KC,Chiarelli, F,Trotta, D,Allgrove, J,Dahl-Jorgensen, K(2009).Microvascular and macrovascular complications associated with diabetes in children and adolescents.Pediatr Diabetes,10(Suppl 12),195-203.
15. El Wakf, AM,Hassan, HA,Gharib, NS(2013).Osteoprotective effect of soybean and sesame oils in ovariectomized rats via estrogen-like mechanism.Cytotechnology
16. Epstein, FH,Atkinson, MA,Maclaren, NK(1994).The pathogenesis of insulin-dependent diabetes mellitus.N Engl J Med,331,1428-1436.
17. Erqou, S,Lee, CT,Suffoletto, M,Echouffo-Tcheugui, JB,de Boer, RA,van Melle, JP(2013).Association between glycated haemoglobin and the risk of congestive heart failure in diabetes mellitus: Systematic review and meta-analysis.Eur J Heart Fail,15,185-193.
18. Fonseca, V,Clark, NG(2006).Standards of medical care in diabetes response to power.Diabetes Care,29,476-477.
19. Fowler, MJ(2008).Microvascular and macrovascular complications of diabetes.Clin Diabetes,26,77-82.
20. Gray, A,Fenn, P,McGuire, A(1995).The cost of insulin-dependent diabetes mellitus (IDDM) in England and Wales.Diabet Med,12,1068-1076.
21. Greenland, P,Alpert, JS,Beller, GA,Benjamin, EJ,Budoff, MJ,Fayad, ZA(2010).American College of Cardiology Foundation, American Heart Association. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol,56,e50-e103.
22. Haidari, F,Omidian, K,Rafiei, H,Zarei, M,Mohamad Shahi, M(2013).Green Tea (Camellia sinensis) supplementation to diabetic rats improves serum and hepatic oxidative stress markers.Iran J Pharm Res,12,109-114.
23. Hanzawa, F,Nomura, S,Sakuma, E,Uchida, T,Ikeda, S(2013).Dietary sesame seed and its lignan, sesamin, increase tocopherol and phylloquinone concentrations in male rats.J Nutr,143,1067-1073.
24. Hong, L,Yi, W,Liangliang, C,Juncheng, H,Qin, W,Xiaoxiang, Z(2012).Hypoglycaemic and hypolipidaemic activities of sesamin from sesame meal and its ability to ameliorate insulin resistance in KK-Ay mice.J Sci Food Agric,93,1833-1838.
25. Hong, YJ,Kim, N,Lee, K,Hee Sonn, C,Eun Lee, J,Tae Kim, S(2012).Korean red ginseng (Panax ginseng) ameliorates type 1 diabetes and restores immune cell compartments.J Ethnopharmacol,144,225-233.
26. Hsu, DZ,Liu, CT,Chu, PY,Li, YH,Periasamy, S,Liu, MY(2013).Sesame oil attenuates ovalbumin-induced pulmonary edema and bronchial neutrophilic inflammation in mice.Biomed Res Int,2013,905670.
27. Ikemoto, T,Sugimoto, K,Takita, M,Shimoda, M,Noguchi, H,Naziruddin, B(2011).Japanese herbal medicine TJ-48 prevents autoimmune diabetes in NOD mice.Am J Chin Med,39,743-756.
28. Jeng, KC,Hou, RC(2005).Sesamin and desamolin: Nature’s therapeutic lignans.Curr Enzyme Inhib,1,11-20.
29. Jia, W,Gao, W,Tang, L(2003).Antidiabetic herbal drugs officially approved in China.Phytother Res,17,1127-1134.
30. Joensen, LE,Tapager, I,Willaing, I(2013).Diabetes distress in type 1 diabetes-a new measurement fit for purpose.Diabet Med,30,1132-1139.
31. Kramer, CK,Rodrigues, TC,Canani, LH,Gross, JL,Azevedo, MJ(2011).Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes meta-analysis of observational studies.Diabetes Care,34,1238-1244.
32. Laing, SP,Swerdlow, AJ,Slater, SD,Burden, AC,Morris, A,Waugh, NR(2003).Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes.Diabetologia,46,760-765.
33. Lehto, S,Rönnemaa, T,Pyörälä, K,Laakso, M(1999).Poor glycemic control predicts coronary heart disease events in patients with type 1 diabetes without nephropathy.Arterioscler Thromb Vasc Biol,19,1014-1019.
34. Lei, H,Han, J,Wang, Q,Guo, S,Sun, H,Zhang, X(2012).Effects of sesamin on streptozotocin (STZ)-induced NIT-1 pancreatic β-cell damage.Int J Mol Sci,13,16961-16970.
35. Li, GQ,Kam, A,Wong, KH,Zhou, X,Omar, EA,Li, K,Chan, K(2012).Herbal medicines for the management of diabetes.Adv Exp Med Biol,771,396-413.
36. Li, WL,Zheng, HC,Bukuru, J,De, Kimpe, N(2004).Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus.J Ethnopharmacol,92,1-22.
37. Libby, P,Theroux, P(2005).Pathophysiology of coronary artery disease.Circulation,111,3481-3488.
38. Liu, CT,Periasamy, S,Chang, CC,Mo, FE,Liu, MY(2013).Sesame oil therapeutically ameliorates cardiac hypertrophy by regulating hypokalemia in hypertensive rats.JPEN J Parenter Enteral Nutr
39. Liu, JP,Zhang, M,Wang, WY,Grimsgaard, S(2004).Chinese herbal medicines for type 2 diabetes mellitus.Cochrane Database Syst Rev,3,CD003642.
40. Liu, SX,Chou, GC(1996).Review effects of Chinese herbal products on mammalian retinal functions.J Ocul Pharmacol Ther,12,377-386.
41. Mahgoub, MA,Abd-Elfattah, AS(1998).Diabetes mellitus and cardiac function.Mol Cell Biochem,180,59-64.
42. Marcovecchio, ML,Tossavainen, PH,Dunger, DB(2010).Prevention and treatment of microvascular disease in childhood type 1 diabetes.Br Med Bull,94,145-164.
43. Margeirsdottir, HD,Larsen, JR,Brunborg, C,Øverby, NC,Dahl-Jørgensen, K,Norwegian Study Group for Childhood Diabetes(2008).High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: A population-based study.Diabetologia,51,554-561.
44. McVeigh, GE,Gibson, W,Hamilton, PK(2013).Cardiovascular risk in the young type 1 diabetes population with a low 10-year, but high lifetime risk of cardiovascular disease.Diabetes Obes Metab,15,198-203.
45. Miura, T,Noda, M,Fukunaga, T,Furuta, K(1997).Hypoglycemic activity of to-kai-san (Chinese medicines) in normal and KK-Ay mice.J Nutr Sci Vitaminol,43,11-17.
46. Moore, DJ,Gregory, JM,Kumah-Crystal, YA,Simmons, JH(2009).Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence.Vas Health Risk Manag,5,1015-1031.
47. Narayan, KV,Boyle, JP,Thompson, TJ,Sorensen, SW,Williamson, DF(2003).Lifetime risk for diabetes mellitus in the United States.JAMA,290,1884-1890.
48. Nathan, DM,Cleary, PA,Backlund, JY,Genuth, SM,Lachin, JM,Orchard, TJ(2005).Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.N Engl J Med,353,2643-2653.
49. Orchard, TJ,Olson, JC,Erbey, JR,Williams, K,Forrest, KY,Smithline Kinder, L(2003).Insulin resistance–related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study.Diabetes Care,26,1374-1379.
50. Orchard, TJ,Secrest, AM,Miller, RG,Costacou, T(2010).In the absence of renal disease, 20-year mortality risk in type 1 diabetes is comparable to that of the general population: A report from the Pittsburgh Epidemiology of Diabetes Complications Study.Diabetologia,53,2312-2319.
51. Ozkol, H,Tuluce, Y,Dilsiz, N,Koyuncu, İ(2013).Therapeutic potential of some plant extracts used in Turkish traditional medicine on streptozocininduced type 1 diabetes mellitus in rats.J Membr Biol,246,47-55.
52. Ponchiardi, C,Mauer, M,Najafian, B(2013).Temporal profile of diabetic nephropathy pathologic changes.Curr Diabetes Rep,13,592-599.
53. Raman, A,Lau, C(1996).Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae).Phytomedicine,2,349-362.
54. Ramesh, B,Saravanan, R,Pugalendi, KV(2005).Influence of sesame oil on blood glucose, lipid peroxidation, and antioxidant status in streptozotocin diabetic rats.J Med Food,8,377-381.
55. Reichard, P,Nilsson, BY,Rosenqvist, U(1993).The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.N Engl J Med,329,304-309.
56. Sankar, D,Ali, A,Sambandam, G,Rao, R(2011).Sesame oil exhibits synergistic effect with anti-diabetic medication in patients with type 2 diabetes mellitus.Clin Nutr,30,351-358.
57. Shu, XS,Lv, JH,Tao, J,Li, GM,Li, HD,Ma, N(2009).Antihyperglycemic effects of total flavonoids from Polygonatum odoratum in STZ and alloxan-induced diabetic rats.J Ethnopharmacol,124,539-543.
58. Silverstein, J,Klingensmith, G,Copeland, K,Plotnick, L,Kaufman, F,Laffel, L(2005).American Diabetes Association. A. Care of children and adolescents with type 1 diabetes. A statement of the American Diabetes Association.Diabetes Care,28,186-212.
59. Skrivarhaug, T,Bangstad, HJ,Stene, LC,Sandvik, L,Hanssen, KF,Joner, G(2006).Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway.Diabetologia,49,298-305.
60. Soltesz, G,Patterson, CC,Dahlquist, G,EURODIAB Study Group(2007).Worldwide childhood type 1 diabetes incidence–what can we learn from epidemiology?.Pediatr Diabetes,8(Suppl 6),6-14.
61. Spinetti, G,Kraenkel, N,Emanueli, C,Madeddu, P(2008).Diabetes and vessel wall remodelling: From mechanistic insights to regenerative therapies.Cardiovasc Res,78,265-273.
62. Stephenson, J,Fuller, JH(1994).Microvascular and acute complications in IDDM patients: The EURODIAB IDDM Complications Study.Diabetologia,37,278-285.
63. Trimeche, A,Selmi, Y,Ben Slama, F,Ben Amara, H,Hazar, I,Ben Mami, F(2013).Effect of protein restriction on renal function and nutritional status of type 1 diabetes at the stage of renal impairment.Tunis Med,91,121-126.
64. UKPDS Group,UKPDS Group(1991).UK Prospective Diabetes Study VIII: Study design, progress and performance.Diabetologia,34,877-890.
65. US Department of Health and Human Services, Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
66. Vanninen, E,Uusitupa, M,Siitonen, O,Laitinen, J,Länsimies, E(1992).Habitual physical activity, aerobic capacity and metabolic control in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus: Effect of 1-year diet and exercise intervention.Diabetologia,35,340-346.
67. Wadén, J,Forsblom, C,Thorn, LM,Gordin, D,Saraheimo, M,Groop, PH,Finnish Diabetic Nephropathy Study Group(2009).A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.Diabetes,58,2649-2655.
68. Watanabe, K,Matsuura, K,Gao, P,Hottenbacher, L,Tokunaga, H,Nishimura, K(2011).Traditional Japanese Kampo medicine: Clinical research between modernity and traditional medicine—the state of research and methodological suggestions for the future.Evid Based Complement Alternat Med,2011,513842.
69. Welschen, LM,Bloemendal, E,Nijpels, G,Dekker, JM,Heine, RJ,Stalman, WA(2005).Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: A systematic review.Cochrane Database Syst Rev,2,CD005060.
70. World Health Organization. Diabetes facts [Online]. Available from: http://www.who.int/mediacentre/factsheets/fs312/en/index.html [Last accessed on 2013 Jun 20].

1. Zsuzsanna Darula,Virág Demján,Tivadar Kiss,Tamás Csont,Roland Tengölics,Márton Pipicz,Imre Földesi,Gergő Szűcs,Flóra Diána Gausz,Dezső Csupor,Andrea Sója,Andrea Siska,Alexandra Fejes(2022).Stellaria media tea protects against diabetes-induced cardiac dysfunction in rats without affecting glucose tolerance.Journal of Traditional and Complementary Medicine,12(3),250-259.